Intellectual Property

  • June 18, 2026

    Bill For AI Deepfake Reporting System Clears Senate Panel

    A bill that would create a pathway for reporting AI-generated deepfakes online for removal cleared the Senate Judiciary Committee on Thursday after a few senators had raised concerns over First Amendment implications but said they believed they could be resolved before a full Senate vote.

  • June 18, 2026

    Starbucks Sues To Block Union From Using Name And Logo

    Starbucks sued Starbucks Workers United on Thursday in Iowa federal court, seeking to block the group from using the company brand and countering a suit the union filed in April.

  • June 18, 2026

    Patent Claims On Novartis Unit Drug Invalid, Del. Judge Says

    A Delaware federal judge has cleared radiopharmaceutical companies of allegations they infringed claims in various patents owned by a French unit of Novartis after finding that all of those claims were invalid.

  • June 17, 2026

    Eve Legal Accused By AI.Law Of Infringing AI Drafting Tech

    Eve Legal ripped off legal tech company AI.Law's patent that allows lawyers and other legal professionals to use artificial intelligence to generate legal documents, AI.Law alleged in a patent infringement lawsuit filed Wednesday in California federal court.

  • June 17, 2026

    Eli Lilly Urges Full Fed. Circ. To Scrap Teva's $177M IP Win

    Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision runs afoul of the justices' Amgen holding and "opens a truck-sized hole in enablement and written description law."

  • June 17, 2026

    Acer Can't Nix Texas Jury's $10M Verdict Over Monitor Patents

    A Texas federal judge rejected Acer's effort to wipe out a jury's $10.3 million infringement award to rival SVV Technology Innovations over optical-film patents for monitors, finding the jury's verdict was supported by the evidence and the company's criticism of an SVV expert's methodology is too late.

  • June 17, 2026

    Hikma Ruling Raises Patent Pleading Bar Beyond Drug Cases

    The U.S. Supreme Court's decision this month that shut down a patent suit against Hikma Pharmaceuticals USA over a drug using a so-called skinny label could also make it more challenging to plead induced infringement in cases involving other technologies, attorneys say.

  • June 17, 2026

    Sen. Committee Clears Drug Disclosure, Biosimilar Bills

    The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need for more interchangeable biosimilars.

  • June 17, 2026

    ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review

    Masimo Corp. and the U.S. International Trade Commission have pushed back on Apple's request for full Federal Circuit rehearing of a panel decision finding an older version of the Apple Watch infringes Masimo's patents, saying Wednesday the case isn't exceptional enough for such scrutiny.

  • June 17, 2026

    Amazon Urges Fed. Circ. To Halt Patent Suit In Texas

    Amazon has asked the Federal Circuit to force a Texas federal court to pause a suit accusing it of infringing a pair of Headwater Research LLC patents while a similar suit against Google plays out.

  • June 17, 2026

    Del. Court Invalidates Patent Claims In Bioscience Co. Row

    A federal magistrate judge in Delaware on Wednesday found that claims in three molecular labeling patents held by Parse Biosciences Inc. were invalid, months after he found that they weren't infringed by Scale Biosciences Inc.

  • June 17, 2026

    Fed. Circ. Affirms No Block On Stryker Spine Device In IP Fight

    The Federal Circuit on Wednesday agreed with a lower court decision rejecting Boston Scientific Corp.'s request to temporarily block Stryker Corp. from launching a back pain device, saying Stryker made a good enough case that it didn't cause physicians to infringe a patent on the treatment.

  • June 17, 2026

    Adobe Faces Derivative Claims For AI Copyright Infringement

    Executives and directors of Adobe have been hit with a derivative suit from investors accusing them of exposing the software giant to financial and reputational harm by concealing that the company used copyrighted material to create artificial intelligence tools.

  • June 17, 2026

    Nasdaq Private Market Says Rival Poached Staff And Secrets

    A Nasdaq marketplace for pre-IPO stock has filed suit against a competitor, alleging that it has poached employees and clients, stolen trade secrets and other confidential information, and infringed its patented technology in an effort to acquire what Nasdaq has built without fairly competing.

  • June 17, 2026

    Sanctioned IP Atty Tells Fed. Circ. 'Integrity' On The Line

    An attorney who was sanctioned in a trade dress infringement case due to what a judge said were his repeated misrepresentations has asked the Federal Circuit to lift the penalties against him and his client, saying his "professional and personal integrity, and my family, depends on it."

  • June 17, 2026

    Meta Trims But Can't Toss Eminem Publishers' $109M IP Suit

    A Michigan federal judge has found Eminem's music publishers can proceed with claims accusing Meta of unlawfully putting hundreds of the rapper's songs in Facebook, Instagram and WhatsApp music libraries, but dismissed their claims that the technology giant should be liable for users sharing or reusing the songs.

  • June 17, 2026

    Justices Asked To Review 'Headscratching' Copyright Ruling

    A group of major music publishers has asked the U.S. Supreme Court to rein in a "headscratching" Fifth Circuit ruling that the music publishers say transformed U.S. copyright termination rights into a worldwide reset button for ownership of foreign copyrights.

  • June 17, 2026

    Sunoco Tells High Court It Was Denied Fair Patent Damages

    Sunoco wants the U.S. Supreme Court to hear its argument that it was shortchanged when it won "a mere $12 million" in a gasoline blending patent suit against Magellan Midstream, saying it wasn't given the opportunity to show that it actually lost more than 12 times that amount.

  • June 17, 2026

    Pickleball Paddle Maker Settles With Rival In ITC Patent Probe

    A pickleball paddle maker has reached a settlement with one of the companies it targeted at the U.S. International Trade Commission with claims of infringing a patent, removing the rival from the probe.

  • June 16, 2026

    Midjourney Faces Discovery Limits Into Studios' AI Use

    A California federal magistrate judge Monday ordered Disney, Universal and Warner Bros. to produce some data on their own use of artificial intelligence in the studios' copyright lawsuit against Midjourney, finding that some requested information is appropriate, but Midjourney's broader requests are irrelevant or shielded under work product privileges.

  • June 16, 2026

    FIFA Mural Suit, Other Fights Showcase 'Obscure' Art Law

    As soccer heavyweights and underdogs square off in the FIFA World Cup, the sport's worldwide governing body is staring down a suit claiming the organization destroyed a mural and violated a unique intellectual property protection that has a history of thwarting the removal of public pieces of art.

  • June 16, 2026

    THC Drink Co. Hid Auto-Renewal Fee, Calif. Suit Claims

    The maker of cannabis-infused beverage Brez intentionally concealed automatic renewal terms on its website in "small" gray font in order to charge an online shopper a recurring $54.21 subscription fee, according to a Los Angeles County lawsuit, which will be getting a new judge, according to a Monday order.

  • June 16, 2026

    Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

    Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties. 

  • June 16, 2026

    Amazon Says YouTubers' DMCA Suit Rests On 'Guesswork'

    Amazon has urged a Seattle federal court to toss three YouTube creators' proposed Digital Millennium Copyright Act class action that accuses the e-commerce giant of scraping millions of copyright-protected videos to train its generative artificial intelligence model Nova Reel, saying the YouTubers' failure to link it to certain datasets makes their allegations "entirely speculative."

  • June 16, 2026

    Del. Judge Won't Touch Jury's $83M Diagnostics IP Verdict

    A Delaware federal judge on Tuesday upheld a jury's 2023 verdict finding that Guardant Health Inc. should pay TwinStrand Biosciences Inc. $83.4 million for willfully infringing diagnostic patents, refusing to overturn or enhance the award.

Expert Analysis

  • Columbia Software IP Ruling Tests Royalty Damages Model

    Author Photo

    The Federal Circuit's recent decision in Columbia University v. Gen Digital, vacating a damages verdict involving foreign software sales, provides guidance on ambiguities surrounding the worldwide royalty damages model established by the court's decision in Brumfield v. IBG two years ago, say attorneys at Munger Tolles.

  • 2 'Rocket Dockets' And The Rules That Propel Them

    Author Photo

    The fastest civil trial courts in the country are currently in the Eastern District of Virginia and the Southern District of Florida, and their chief judges provide insights into the court rules that keep them ahead, says Robert Tata at Hunton.

  • AI Practices To Protect Trade Secrets Amid Unstable Case Law

    Author Photo

    Amid recent diverging district court approaches to whether inputting proprietary information into artificial intelligence tools could constitute a failure to take reasonable measures to safeguard secrets, trade secret owners must adapt their confidentiality practices to keep trade secrets secure, says Fitz Collings at MoFo.

  • Teva Ruling Offers Patentees New Support For Genus Claims

    Author Photo

    The Federal Circuit's recent decision in Teva v. Eli Lilly, finding that the Teva patents at issue are not invalid, offers an interesting counterexample against the recent trend of courts invalidating patents claiming a broad, functionally defined class of compounds, say attorneys at Cooley.

  • Defense Patent Holiday's Real Prize May Be Collab Potential

    Author Photo

    The true value of participating in the ongoing defense patent holiday program might lie not in access to technology developed by the U.S. Department of War, but in developing a working relationship with a federally funded lab and potentially achieving a cooperative research and development agreement, says Lawrence Kass at Steptoe.

  • Your Next Litigation Hold Should Cover AI Chat Logs

    Author Photo

    The Delaware Chancery Court’s recent decision in Fortis Advisors v. Krafton to treat a CEO’s artificial intelligence chats as substantive evidence is being read as a discovery warning to litigators, but there is a second duty-to-preserve lesson that is especially pertinent to in-house counsel, say attorneys at Faegre Drinker.

  • Opinion

    International Patent Licensing System Must Be Maintained

    Author Photo

    As foreign approaches to patent enforcement threaten to distort the licensing markets that underpin modern technology, courts and policymakers must take action to ensure that the standard essential patent framework is preserved, says Brian O'Shaughnessy at Dinsmore.

  • Series

    Studying Foreign Languages Makes Me A Better Lawyer

    Author Photo

    Studying Italian and Japanese has shown me that learning a new language can benefit a legal career in several ways, including by demonstrating the importance of approaching problems from a fresh perspective and the value of practicing patience with colleagues and clients, says Anna King at Genworth Financial.

  • 10 US Patent Pressure Points For EU Life Sciences Cos.

    Author Photo

    U.S.-specific patent issues can be challenging for European life sciences companies because they require decisions at the intersection of legal, scientific, regulatory and commercial functions, necessitating proactive, cross-functional steps from EU patent counsel, says Paul Calvo at Sterne Kessler.

  • And Now A Word From The Panel: An MDL Realignment

    Author Photo

    With seven multidistrict litigation proceedings initiated so far this year, a review of venue locations suggests a shift away from the East Coast, a seeming reversal of last year's swing in that direction, says Alan Rothman at Sidley.

  • NIL Contracts Test Limits On College Football Transfers

    Author Photo

    College football's new legal era of direct payments to players and fewer transfer restrictions has put contractual provisions in play, and stipulations such as termination clauses and repayment obligations require added scrutiny as the name, image and likeness system evolves, says Kevin Paule at Hill Ward Henderson.

  • Data Center Boom Brings New Patent Risk For Owners

    Author Photo

    As U.S. data center investment surges, owners and operators face rising patent infringement suits targeting entire facility designs rather than individual products — risks that standard vendor indemnities often fail to cover, say attorneys at V&E.

  • 'Anderson Method' Ruling Shows Copyright Limits In Fitness

    Author Photo

    The Ninth Circuit's ruling in Tracy Anderson Mind and Body v. Megan Roup, finding that sequences of exercises developed and recorded by Tracy Anderson were not copyrightable choreographic works, is a reminder that even highly creative fitness programming can fall outside the scope of copyright protection, says Meredith Bobber Strauss at Michelman & Robinson.

  • New USPTO Procedure May Be A Boon For Patent Owners

    Author Photo

    The U.S. Patent and Trademark Office's new ex parte reexamination procedure, allowing patent owners to file preorder papers to inform the EPR decision process, marks the first meaningful opportunity for owners to prevent EPR, say attorneys at Knobbe Martens.

  • What Fed. Circ.'s Poultry Patent Ruling Says About 'About'

    Author Photo

    The Federal Circuit's recent decision in Enviro Tech v. Safe Foods highlights how approximation language in patent claims affects not only litigation outcomes, but also portfolio value, competitive positioning and prosecution strategy, say attorneys at Foley & Lardner.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.